LEGN – legend biotech corporation - american depositary shares (US:NASDAQ)
Stock Stats
News
Legend Biotech (NASDAQ:LEGN) was given a new $50.00 price target on by analysts at Morgan Stanley.
Leading Multiple Myeloma Results Unveiled at ASH 2025: Paradigm-Shifting Data Redefines Treatment Landscape | DelveInsight
Leading Multiple Myeloma Results Unveiled at ASH 2025: Paradigm-Shifting Data Redefines Treatment Landscape | DelveInsight
Legend Biotech Corporation (LEGN) is an Outperform on Multiple Myeloma Treatment CARVYKTI Prospects [Yahoo! Finance]
Legend Biotech (NASDAQ:LEGN) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Form 6-K Legend Biotech Corp For: Dec 08
Form 144 Legend Biotech Corp Filed by: GenScript Corp
Form 6-K Legend Biotech Corp For: Sep 30
Form SCHEDULE 13G/A Legend Biotech Corp Filed by: FMR LLC
Form 6-K Legend Biotech Corp For: Nov 03
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.